M06.349 Rheumatoid nodule, unspecified hand

Name of the Condition

• Rheumatoid nodule, unspecified hand

Summary

Rheumatoid nodule, unspecified hand is a localized extra-articular manifestation of rheumatoid arthritis (RA) involving firm, subcutaneous nodules in the hand region. These nodules are composed of inflammatory tissue and are associated with chronic, seropositive RA. They may occur in other conditions but are most strongly linked to RA. Diagnosis relies on clinical recognition and correlation with underlying joint disease.

Causes

Rheumatoid nodules form due to chronic inflammation and immune complex deposition in subcutaneous tissues. The exact pathogenesis involves dysregulated immune responses, including the activation of fibroblast-like synoviocytes and the production of pro-inflammatory cytokines. Genetic factors, such as HLA-DRB1 alleles, and environmental triggers (e.g., smoking) may contribute to their development in individuals with RA.

Risk Factors

• Severe, long-standing rheumatoid arthritis (especially seropositive disease).
• High rheumatoid factor or anti-CCP antibody titers.
• Presence of other extra-articular RA manifestations (e.g., vasculitis).
• Chronic inflammation and immune dysregulation.
• Trauma or pressure to affected areas.

Symptoms

• Firm, movable subcutaneous nodules in the hand area, often over bony prominences or pressure points.
• Nodules may be painless or tender.
• May be associated with underlying joint inflammation or deformity.

Diagnosis

Diagnosis is primarily clinical, based on the presence of firm, subcutaneous nodules in the hand and correlation with a history of rheumatoid arthritis. Imaging (e.g., ultrasound) may confirm the subcutaneous location, while laboratory tests (e.g., rheumatoid factor, anti-CCP) support the underlying RA diagnosis. Biopsy is rarely needed but can differentiate from other nodular conditions.

Treatment Options

• Disease-modifying antirheumatic drugs (DMARDs): Target underlying RA to reduce inflammation and nodule formation.
• Corticosteroids: May reduce nodule size or tenderness in some cases.
• Local measures: Padding or pressure relief for symptomatic nodules.
• Surgical excision: Considered for painful, ulcerated, or functionally limiting nodules.

Prognosis and Follow-Up

Rheumatoid nodules often persist but may fluctuate with RA disease activity. Prognosis depends on the severity of underlying RA. Regular follow-up with a rheumatologist is recommended to monitor joint disease and adjust treatment as needed.

Complications

• Ulceration or infection of nodules, especially over pressure points.
• Functional impairment if nodules affect hand mobility or dexterity.
• Psychosocial impact due to visible deformity.

Lifestyle & Prevention

• Smoking cessation: Reduces risk of nodule development in RA patients.
• Joint protection: Avoid repetitive trauma or pressure to the hands.
• RA management: Adherence to prescribed DMARD therapy to control systemic inflammation.

When to Seek Professional Help

Seek care if nodules become painful, ulcerate, increase in size, or interfere with hand function. Prompt evaluation is also warranted for new or worsening RA symptoms.

Tips for Medical Coders

Use M06.349 for rheumatoid nodules localized to the unspecified hand. Document the hand location (e.g., left, right, or bilateral) if specified, as this may impact code assignment. Correlate with RA diagnosis and note any associated symptoms or complications to support clinical necessity.